Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: JAMA Dermatol. 2013 Sep 1;149(9):1110–1111. doi: 10.1001/jamadermatol.2013.5104

Indoor tanning and tanning dependence in young people after a diagnosis of basal cell carcinoma

Brenda Cartmel 1,2, Leah M Ferrucci 3, Peter Spain 4, Allen E Bale 5,6, Sherry L Pagoto 7, David J Leffell 8,9, Joel Gelernter 10, Susan T Mayne 11,12
PMCID: PMC3782995  NIHMSID: NIHMS507346  PMID: 23824273

Individuals who have had basal cell carcinoma (BCC) are at high risk of subsequent BCCs and melanoma.1 Indoor tanning is an established risk factor for BCC, squamous cell carcinoma and melanoma.2 As such, continuing to tan indoors after a BCC diagnosis may elevate one’s risk for future skin cancers. Skin cancer survivors have sun protection behaviors that are similar to those of the general population,3 but little is known about their indoor tanning behavior. Notably, research suggests some individuals develop tanning dependence, analogous to substance dependence,4 which could be related to continued indoor tanning. To understand better the patterns of and reasons for indoor tanning after BCC diagnosis, we assessed indoor tanning and symptoms of tanning dependence in people who had at least one BCC before age 40.

Methods

Non-Hispanic whites in Connecticut diagnosed with BCC before age 40 who participated in a case-control study of BCC5 were recontacted 1– 4 years post-diagnosis to complete an online survey (response rate= 80.9%). The study was approved by the Yale School of Medicine Human Investigation Committee. We assessed indoor tanning in the past year, and lifetime symptoms of tanning dependence using the modified 4-item “Cut down, Annoyed, Guilty, Eye-opener” (mCAGE) Questionnaire4. Participants were classified as having symptoms of tanning dependence with two or more affirmative responses on the mCAGE. History of indoor tanning prior to BCC diagnosis (e.g. age at initiation, number of indoor tanning sessions) had been collected during the case-control study.

This analysis is limited to those who reported indoor tanning prior to BCC diagnosis. We evaluated differences by indoor tanning after BCC diagnosis using the chi-squared test, Fisher’s Exact Test, and Wilcoxon Rank Sum Test.

Results

Among the 178 individuals who had tanned indoors prior to BCC diagnosis, 26 (14.6%) reported tanning indoors in the past year. The median number of indoor tanning sessions in the past year was 10 in those who tanned indoors [interquartile range (IQR) = 3–20]. Those who reported tanning indoors after BCC diagnosis were similar to those who did not (Table 1), with the exception of the frequency of indoor tanning prior to BCC diagnosis being much higher in those who continued to tan indoors after diagnosis (p-value=0.001). In addition, those who tanned indoors after BCC diagnosis were more likely to have symptoms of tanning dependence (57.7%) than those who had not tanned indoors since diagnosis (38.2%) (p-value=0.06).

Table 1.

Selected characteristics by indoor tanning after diagnosis

Tanned Indoors After
BCC Diagnosis
N=26
N1 (%) or
Median (IQR)
Did Not Tan Indoors
After BCC Diagnosis
N=152
N1 (%) or
Median (IQR)
Age at online survey (y) 40.0 (34.4–42.6) 40.1(36.4–41.8)
Age at BCC diagnosis (y) 37.5 (30.9–38.9) 36.3 (33.1–38.4)
Female 21(80.8) 132 (86.8)
>1 BCC under age 40 7 (26.9) 62 (40.8)
Skin color (inner upper arm)
  Olive 8 (30.8) 48 (31.6)
  Fair 18 (69.2) 94 (61.8)
  Very fair 0 (0.0) 10 (6.6)
Family history of skin cancer 3 (11.5) 38 (25.0)
Age started indoor tanning (y) 17.5 (16.0–20.0) 18.0 (16.0–21.0)
Indoor tanning sessions before BCC 175 (111–324) 33.5 (8–150)2
Burned from indoor tanning before BCC 14 (53.8) 60 (39.5)
Symptoms of tanning dependence 15 (57.7) 58 (38.2)3
1

May not sum to total due to missing data.

2

P-value=0.001; Wilcoxon Rank Sum Test.

3

P-value=0.06; X2 test.

IQR: Inter-quartile Range

Comments

Despite mounting evidence of the harmful effects of indoor tanning, in this group of young people who already had at least one BCC, nearly 15% tanned indoors after their skin cancer diagnosis and 7.9% would be defined as frequent indoor tanners (≥10 sessions/year). Notably, individuals with BCC who tanned indoors after diagnosis were more likely to have symptoms of tanning dependence than those who did not tan indoors following BCC diagnosis, suggesting that tanning dependence may contribute to continued indoor tanning in spite of health consequences. A similar phenomenon is observed wherein nicotine dependent individuals sometimes continue to smoke after a tobacco-related cancer diagnosis.

Our findings would benefit from replication, but suggest that clinicians should discuss the risks of tanning indoors with BCC survivors who continue this behavior and be cognizant of tanning dependence, which can be assessed clinically with a recently validated measure6.

Acknowledgments

Funding/Support: This study was supported in part by NIH/NCI: R21 CA155952 and P50 CA121974

Footnotes

Author Contributions: Dr Cartmel had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Bale, Cartmel, Ferrucci, Gelernter, Leffell, Mayne and Pagoto. Analysis and interpretation of data: Cartmel and Ferrucci. Drafting of the manuscript: Cartmel, Ferrucci, and Mayne. Critical revision of the manuscript for important intellectual content: Bale, Cartmel, Ferrucci, Gelernter, Leffell, Mayne, Pagoto, Spain. Study supervision: Cartmel, Spain.

None of the authors have any financial disclosure or conflict of interest to report.

Contributor Information

Brenda Cartmel, Yale School of Public Health, New Haven Yale Cancer Center, New Haven.

Leah M. Ferrucci, Yale School of Public Health, New Haven

Peter Spain, Yale School of Public Health, New Haven.

Allen E. Bale, Yale Cancer Center, New Haven Yale University School of Medicine, New Haven.

Sherry L. Pagoto, University of Massachusetts Medical School, Worcester

David J. Leffell, Yale Cancer Center, New Haven Yale University School of Medicine, New Haven.

Joel Gelernter, Yale University School of Medicine, New Haven

Susan T. Mayne, Yale School of Public Health, New Haven Yale Cancer Center, New Haven.

References

  • 1.Chen J, Ruczinski I, Jorgensen TJ, et al. Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst. 2008 Sep 3;100(17):1215–1222. doi: 10.1093/jnci/djn260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Boniol M, Autier P, Boyle P, Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ. 2012;345:e4757. doi: 10.1136/bmj.e4757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Mujumdar UJ, Hay JL, Monroe-Hinds YC, et al. Sun protection and skin self-examination in melanoma survivors. Psychooncology. 2009 Oct;18(10):1106–1115. doi: 10.1002/pon.1510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Nolan BV, Taylor SL, Liguori A, Feldman SR. Tanning as an addictive behavior: a literature review. Photodermatol Photoimmunol Photomed. 2009 Feb;25(1):12–19. doi: 10.1111/j.1600-0781.2009.00392.x. [DOI] [PubMed] [Google Scholar]
  • 5.Ferrucci LM, Cartmel B, Molinaro AM, et al. Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma. J Invest Dermatol. 2012 Apr;132(4):1272–1279. doi: 10.1038/jid.2011.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hillhouse JJ, Baker MK, Turrisi R, et al. Evaluating a measure of tanning abuse and dependence. Arch Dermatol. 2012;148(7):815–819. doi: 10.1001/archdermatol.2011.2929. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES